This study is in progress, not accepting new patients
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by April W. Armstrong, MD, MPH
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- April W. Armstrong, MD, MPH
Dr. April Armstrong is Professor and Chief of Dermatology at University of California Los Angeles (UCLA). She oversees and leads the dermatology division, including managing clinical operations and promoting research and education. She also serves as Co-Director for Network Resources at the UCLA Clinical and Translational Research Institute.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Apollo Therapeutics Ltd
- Links
- Sign up for this study
- ID
- NCT06436183
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- About 62 people participating
- Last Updated